Director MORIKIS JOHN G buys 1,250 shares of JNJ for $257.7K, tripling holdings from 598 to 1,848 shares.
MORIKIS JOHN G purchased 1,250 shares at $206.15, increasing his JNJ position by 208.9% to 1,848 shares post-transaction. The purchase occurred near the 52-week high of $207.56 and follows a strong recent momentum window: the stock has appreciated 8.7% over 30 days and 15.3% over 90 days. His cross-ticker track record shows 2 prior buys with an average 90-day return of 28.4% and a 100% win rate, suggesting a pattern of well-timed accumulations across different holdings. The sustained accumulation in JNJ—building holdings from a modest 598 shares—is notable given the company's solid fundamentals: $24.0B quarterly revenue, $5.2B net income, and a market cap of $494.7B. This material increase in position size merits investor attention as a substantive directional commitment by a director during a period of positive price momentum.
Executive Chairman Morikis sells 115,969 shares at $363.79–$365.54 for $42.3M; stock at 52-week high.
John G. Morikis, Executive Chairman of Sherwin Williams, executed 3 separate sales on 2024-08-30 totaling 115,969 shares for $42,275,049.61, reducing his holdings by 24.0% from 482,515 to 366,546 shares. The blended average sale price of $364.54 sits near the stock's 52-week high of $369.37 and well above the current price of $362.70. His prior trades at SHW—both buys on 2023-10-25—were well-timed at the 90-day mark, but that pattern cannot inform the timing of this sale without future price action. The filing shows a significant reduction in the executive's direct ownership stake at elevated valuations.
